ArticleFrontiers in nutrition2026
Association of adherence to the EAT-Lancet diet and risk of uterine cancer: a prospective cohort from the UK Biobank.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The EAT-Lancet dietary pattern is a healthy eating model linked to multiple health benefits. However, whether it is associated with uterine cancer, including malignancies of the isthmus uteri, endometrium, myometrium, fundus uteri, overlapping lesions of the corpus uteri, and uterus of unspecified site, remains unexplored. Methods: This study comprised 114,572 women without uterine cancer at baseline. Participants who had at least one 24-h dietary recall record in the UK Biobank were included. Cox proportional hazards models were applied to estimate hazard ratios (HRs) and 95% confidence intervals (95% CIs) for incident uterine cancer across the EAT-Lancet diet index. Cox proportional hazards models were adjusted for age, ethnicity, Townsend Deprivation Index, total energy intake, smoking status, alcohol intake, and physical activity. Results: This study had an average follow-up period of 13.26 years. During this time, 694 new cases of uterine cancer were recorded. Participants with higher adherence to the EAT-Lancet diet (index ≥ 12) had a lower risk of uterine cancer than those in the lowest adherence group (HR = 0.706, 95% CI: 0.547-0.911). Each 1-point increase in the EAT-Lancet diet index was associated with 6.9% lower risk of uterine cancer (HR = 0.931, 95% CI: 0.874-0.992). Conclusion: Higher adherence to the EAT-Lancet dietary pattern was associated with a lower risk of uterine cancer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.